Couch F - Search Results

1

A clinical calculator to predict disease outcomes in women with triple-negative breast cancer.

Polley MC, Leon-Ferre RA, Leung S, Cheng A, Gao D, Sinnwell J, Liu H, Hillman DW, Eyman-Casey A, Gilbert JA, Negron V, Boughey JC, Liu MC, Ingle JN, Kalari K, Couch F, Carter JM, Visscher DW, Nielsen TO, Goetz MP. Polley MC, et al. Among authors: couch f. Breast Cancer Res Treat. 2021 Feb;185(3):557-566. doi: 10.1007/s10549-020-06030-5. Epub 2021 Jan 3. Breast Cancer Res Treat. 2021. PMID: 33389409 Free PMC article. Review.

2

p73 mutations are not detected in sporadic and hereditary breast cancer.

Schwartz DI, Lindor NM, Walsh-Vockley C, Roche PC, Mai M, Smith DI, Liu W, Couch FJ. Schwartz DI, et al. Among authors: couch fj. Breast Cancer Res Treat. 1999 Nov;58(1):25-9. doi: 10.1023/a:1006237031070. Breast Cancer Res Treat. 1999. PMID: 10634515

3

17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes.

Wu GJ, Sinclair CS, Paape J, Ingle JN, Roche PC, James CD, Couch FJ. Wu GJ, et al. Among authors: couch fj. Cancer Res. 2000 Oct 1;60(19):5371-5. Cancer Res. 2000. PMID: 11034073

4

Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors.

Wu G, Sinclair C, Hinson S, Ingle JN, Roche PC, Couch FJ. Wu G, et al. Among authors: couch fj. Cancer Res. 2001 Jul 1;61(13):4951-5. Cancer Res. 2001. PMID: 11431322

5

TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.

Sinclair CS, Adem C, Naderi A, Soderberg CL, Johnson M, Wu K, Wadum L, Couch VL, Sellers TA, Schaid D, Slezak J, Fredericksen Z, Ingle JN, Hartmann L, Jenkins RB, Couch FJ. Sinclair CS, et al. Cancer Res. 2002 Jul 1;62(13):3587-91. Cancer Res. 2002. PMID: 12097257

6

The 17q23 amplicon and breast cancer.

Sinclair CS, Rowley M, Naderi A, Couch FJ. Sinclair CS, et al. Breast Cancer Res Treat. 2003 Apr;78(3):313-22. doi: 10.1023/a:1023081624133. Breast Cancer Res Treat. 2003. PMID: 12755490 Review.

7

Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomas.

Miller DV, Leontovich AA, Lingle WL, Suman VJ, Mertens ML, Lillie J, Ingalls KA, Perez EA, Ingle JN, Couch FJ, Visscher DW. Miller DV, et al. Mod Pathol. 2004 Jul;17(7):756-64. doi: 10.1038/modpathol.3800114. Mod Pathol. 2004. PMID: 15073601 Free article.

8

Targeted Therapy for BRCA2 Deficient Tumors.

Goetz M, Couch FJ. Goetz M, et al. Cancer Biol Ther. 2005 Jul;4(7):707-8. doi: 10.4161/cbt.4.7.1998. Epub 2005 Jul 20. Cancer Biol Ther. 2005. PMID: 16123599 Free article. No abstract available.

9

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.

Goetz MP, Rae JM, Suman VJ, Safgren SL, Ames MM, Visscher DW, Reynolds C, Couch FJ, Lingle WL, Flockhart DA, Desta Z, Perez EA, Ingle JN. Goetz MP, et al. J Clin Oncol. 2005 Dec 20;23(36):9312-8. doi: 10.1200/JCO.2005.03.3266. J Clin Oncol. 2005. PMID: 16361630

10

A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen.

Goetz MP, Suman VJ, Ingle JN, Nibbe AM, Visscher DW, Reynolds CA, Lingle WL, Erlander M, Ma XJ, Sgroi DC, Perez EA, Couch FJ. Goetz MP, et al. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2080-7. doi: 10.1158/1078-0432.CCR-05-1263. Clin Cancer Res. 2006. PMID: 16609019 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

707 results

Search Page

Filters